Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Management of Insomnia

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

Antiepileptic Drugs: Glutamate Antagonists

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

Pharmaceutical Poisoning: Treatment Strategies

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Fremanezumab and erenumab for migraine prophylaxis - real-world data from Hungary].

Ideggyogyaszati szemle·2026

Same author

Discordant ADC and DWI signal evolution in hyperacute stroke: implications for early imaging interpretation.

Neuroradiology·2026

Same author

[Joint practical guideline of the Hungarian Pain Society Chronic Headache Working Group and the Hungarian Headache Society on the use of calcitonin gene-related peptide (CGRP)-targeting therapies in migraine].

Orvosi hetilap·2025

Same author

Singing for memory: neural and cognitive effects of a choral intervention in older adults.

Frontiers in aging neuroscience·2025

Same author

Workload and clinical impact of MRI-based extension of reperfusion therapy time window in acute ischaemic stroke-a prospective single-centre study.

GeroScience·2025

Same author

Personality traits and psychological complaints under patients suffering from headaches.

Ideggyogyaszati szemle·2023

Search research articles

Related Experiment Video

Updated: Mar 28, 2026

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders

Published on: November 1, 2024

[Current pharmacotherapy in migraine].

Éva Csépány¹, Máté Magyar, Tamás Gyüre

¹Semmelweis University Szentágothai János Doctoral School of Neuroscience, Budapest, Hungary. ertsey.csaba@med.semmelweis-univ.hu.

Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet Lapja = Official Journal of the Hungarian Association of Psychopharmacology

|January 5, 2016

Summary

Migraine research needs improvement due to unknown causes and ineffective treatments. New experimental drugs show promise, but further studies are essential for better migraine management.

More Related Videos

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

Related Experiment Videos

Last Updated: Mar 28, 2026

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders

Published on: November 1, 2024

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Investigating Migraine-Like Behavior Using Light Aversion in Mice

Published on: August 11, 2021

Area of Science:

Neurology
Pharmacology

Context:

Migraine pathophysiology remains largely unknown, hindering diagnostic biomarker development.
Current animal models offer incomplete insights into migraine mechanisms.
Existing acute and preventive migraine therapies are suboptimal and may have significant side effects.

Purpose:

To highlight the critical need for further research in migraine.
To underscore the limitations of current diagnostic and therapeutic strategies.
To emphasize the necessity of evaluating novel migraine drug candidates.

Summary:

The precise pathomechanism of migraine is not understood, and there are no diagnostic biomarkers.
Current migraine treatments, including triptans and ergot alkaloids, are not universally effective and can lead to medication overuse headache.
While new experimental drugs show potential, extensive research is required due to limited experience and possible side effects.

Impact:

Advances in understanding migraine mechanisms could lead to the development of specific diagnostic biomarkers.
Improved therapeutic strategies are needed to address the limitations of current acute and preventive migraine treatments.
Further investigation into novel drug candidates is crucial for advancing migraine therapy and patient care.